Kovitz Investment Group Partners, LLC, an investment management company, released its “Kovitz Core Equity Strategy” ...

Medical technology company Becton, Dickinson and Company (NYSE:BDX) met Wall Street’s revenue expectations in Q2 CY2025, with ...

Heartland Advisors’ Q2 2025 report highlights tactical trims, rising cash, and key stock picks. See how they’re positioning ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Becton, Dickinson (BDX) stock gains as the company boosts fiscal 2025 earnings outlook after better than expected Q3 results.

Hello, this is your one and only Nana. It’s been a month since my last Death Note Princess Diary… Time flies really fast when you are running around Disney and Universal. In a couple of days, my ...

Becton, Dickinson and Company (NYSE:BDX) is one of the top stocks that Grok recommended. On July 31, Becton, Dickinson and Company (NYSE:BDX) announced that it submitted an application to the U.S.

Becton Dickinson beat Q3 earnings and revenue estimates, raised its FY25 EPS outlook, and saw strong growth in its medical ...

BD (NYSE: BDX) shares ticked up before hours today on third-quarter results that came in ahead of the consensus Wall Street ...

Becton Dickinson raised its forecast for annual profit on Thursday, after beating Wall Street estimates for third-quarter profit and sales on strong demand for its drug-delivery devices.

The stock's rise snapped a five-day losing streak.

BD (NYSE: BDX) announced today that it plans to invest more than $35 million in U.S.-based prefilled flush syringe ...